Compare Neurocrine Biosciences Inc (NBIX) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Cloudflare Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Cloudflare Inc trades at $271.1 (market cap $96.69B). The key difference: Cloudflare Inc is far larger — about 5.6× Neurocrine Biosciences Inc's market cap. Which is the better fit depends on your goals.
| NBIX | NET | |
|---|---|---|
Market Cap | $17.40B | $96.69B |
Sector | Health | Technology |
52-Week High | $180.55 | $281.69 |
52-Week Low | $123.10 | $160.16 |
Enterprise Value | $16.49B | $96.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
